Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS Negl Trop Dis ; 13(7): e0007473, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-31306420

RESUMEN

The N-linked glycosylation motif at amino acid position 154-156 of the envelope (E) protein of West Nile virus (WNV) is linked to enhanced murine neuroinvasiveness, avian pathogenicity and vector competence. Naturally occurring isolates with altered E protein glycosylation patterns have been observed in WNV isolates; however, the specific effects of these polymorphisms on avian host pathogenesis and vector competence have not been investigated before. In the present study, amino acid polymorphisms, NYT, NYP, NYF, SYP, SYS, KYS and deletion (A'DEL), were reverse engineered into a parental WNV (NYS) cDNA infectious clone to generate WNV glycosylation mutant viruses. These WNV glycosylation mutant viruses were characterized for in vitro growth, pH-sensitivity, temperature-sensitivity and host competence in American crows (AMCR), house sparrows (HOSP) and Culex quinquefasciatus. The NYS and NYT glycosylated viruses showed higher viral replication, and lower pH and temperature sensitivity than NYP, NYF, SYP, SYS, KYS and A'DEL viruses in vitro. Interestingly, in vivo results demonstrated asymmetric effects in avian and mosquito competence that were independent of the E-protein glycosylation status. In AMCRs and HOSPs, all viruses showed comparable viremias with the exception of NYP and KYS viruses that showed attenuated phenotypes. Only NYP showed reduced vector competence in both Cx. quinquefasciatus and Cx. tarsalis. Glycosylated NYT exhibited similar avian virulence properties as NYS, but resulted in higher mosquito oral infectivity than glycosylated NYS and nonglycosylated, NYP, NYF, SYP and KYS mutants. These data demonstrated that amino acid polymorphisms at E154/156 dictate differential avian host and vector competence phenotypes independent of E-protein glycosylation status.


Asunto(s)
Vectores de Enfermedades , Proteínas del Envoltorio Viral/metabolismo , Fiebre del Nilo Occidental/virología , Virus del Nilo Occidental/metabolismo , Aedes , Secuencias de Aminoácidos , Animales , Chlorocebus aethiops , Culex/virología , Culicidae/virología , Modelos Animales de Enfermedad , Femenino , Glicosilación , Concentración de Iones de Hidrógeno , Ratones , Mutación , Fenotipo , Gorriones/virología , Células Vero , Proteínas del Envoltorio Viral/genética , Viremia , Virulencia , Replicación Viral , Virus del Nilo Occidental/genética
2.
Blood ; 112(4): 1259-68, 2008 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-18550855

RESUMEN

Robust T-cell responses without autoimmunity are only possible through a fine balance between activating and inhibitory signals. We have identified a novel modulator of T-cell expansion named proliferation-induced lymphocyte-associated receptor (PILAR). Surface PILAR is markedly up-regulated on CD4 and, to a lesser extent, on CD8 T cells on T-cell receptor engagement. In absence of CD28 costimulation, PILAR signaling through CD161 supports CD3 antibody-dependent and antigen-specificT-cell proliferation by increasing the expression of antiapoptotic Bcl-xL and induces secretion of T helper type 1 cytokines. These effects are abrogated by PILAR blockade with specific antibodies, which decrease surface levels of CD28. In contrast, PILAR induces apoptotic death on naive and early activated T cells if CD161 engagement is blocked. PILAR is expressed by approximately 7% to 10% of CD4 T cells in 2 samples of inflammatory synovial fluid, suggesting a potential role in the pathogenesis of joint inflammation. In addition, in the ovarian cancer microenvironment, effector T cells express PILAR, but not CD161, although expression of both can be augmented ex vivo. Our results indicate that PILAR plays a central role in modulating the extent of T-cell expansion. Manipulation of PILAR signaling may be important for treatment of autoimmune diseases and cancer.


Asunto(s)
Antígenos de Superficie/metabolismo , Proliferación Celular , Lectinas Tipo C/metabolismo , Lectinas Tipo C/fisiología , Activación de Linfocitos/inmunología , Proteínas de la Membrana/fisiología , Transducción de Señal , Linfocitos T/inmunología , Enfermedades Autoinmunes/inmunología , Células Cultivadas , Cromosomas Humanos Par 12 , Femenino , Humanos , Inmunidad Celular , Inflamación/inmunología , Lectinas Tipo C/genética , Proteínas de la Membrana/genética , Subfamilia B de Receptores Similares a Lectina de Células NK , Neoplasias Ováricas/inmunología , Líquido Sinovial/inmunología , Linfocitos T/química , Linfocitos T/citología , Regulación hacia Arriba/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA